Android app Apple app link

Wall Street Has a Mixed Opinion on Roivant Sciences Ltd (ROIV)

By Yahoo! Finance   |   1 month ago
Wall Street Has a Mixed Opinion on Roivant Sciences Ltd (ROIV)

Roivant Sciences Ltd. (NASDAQ: ROIV) is a promising biotechnology company with mixed opinions from analysts following positive results from its Phase 3 VALOR study. Analysts have varying ratings and price targets, highlighting potential growth but also competitive market risks.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.